Subscribe
shutterstock_1066944104_siradawichitaphornkun
Sirada Wichitaphornkun / Shutterstock.com
12 October 2021GenericsAlex Baldwin

Bayer, Meda sue Apotex over nasal spray

Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro (azelastine) patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Apotex asks Supreme Court to overturn Teva ‘Bendeka’ ruling
21 December 2021   Apotex has asked the US Supreme Court to reconsider a US Court of Appeals for the Federal Circuit ruling upholding four of Teva Pharmaceutical’s cancer drug patents.
Americas
Merck Sharp & Dohme fails to secure new nasal spray trial
12 February 2018   The US Court of Appeals for the Federal Circuit denied Merck Sharp & Dohme’s request for a new trial to determine whether Amneal infringed a patent related to a nasal spray on Friday, February 9.
Americas
Endo sues Lupin over nasal spray
2 August 2017   Drugs maker Endo Pharmaceuticals has accused Lupin Atlantis, a subsidiary of Lupin, of patent infringement.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Americas
Apotex asks Supreme Court to overturn Teva ‘Bendeka’ ruling
21 December 2021   Apotex has asked the US Supreme Court to reconsider a US Court of Appeals for the Federal Circuit ruling upholding four of Teva Pharmaceutical’s cancer drug patents.
Americas
Merck Sharp & Dohme fails to secure new nasal spray trial
12 February 2018   The US Court of Appeals for the Federal Circuit denied Merck Sharp & Dohme’s request for a new trial to determine whether Amneal infringed a patent related to a nasal spray on Friday, February 9.
Americas
Endo sues Lupin over nasal spray
2 August 2017   Drugs maker Endo Pharmaceuticals has accused Lupin Atlantis, a subsidiary of Lupin, of patent infringement.

More on this story

Americas
Apotex asks Supreme Court to overturn Teva ‘Bendeka’ ruling
21 December 2021   Apotex has asked the US Supreme Court to reconsider a US Court of Appeals for the Federal Circuit ruling upholding four of Teva Pharmaceutical’s cancer drug patents.
Americas
Merck Sharp & Dohme fails to secure new nasal spray trial
12 February 2018   The US Court of Appeals for the Federal Circuit denied Merck Sharp & Dohme’s request for a new trial to determine whether Amneal infringed a patent related to a nasal spray on Friday, February 9.
Americas
Endo sues Lupin over nasal spray
2 August 2017   Drugs maker Endo Pharmaceuticals has accused Lupin Atlantis, a subsidiary of Lupin, of patent infringement.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?